(Q51253555)

2 April 2018

title

Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up. (English)

1 reference

2 April 2018

author name string

Shinya Komori

series ordinal

1

1 reference

2 April 2018

Kyoko Ishida

series ordinal

2

1 reference

2 April 2018

Tetsuya Yamamoto

series ordinal

3

1 reference

2 April 2018

publication date

17 August 2014

1 reference

2 April 2018

Graefe's Archive for Clinical and Experimental Ophthalmology

published in

1 reference

2 April 2018

volume

252

1 reference

2 April 2018

page(s)

1963-1970

1 reference

2 April 2018

issue

12

1 reference

2 April 2018

https://scigraph.springernature.com/pub.10.1007/s00417-014-2767-3

exact match

0 references

cites work

Predictors of long-term progression in the early manifest glaucoma trial

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Intraocular pressure reduction in normal-tension glaucoma patients in South Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Risk factors for progression of visual field abnormalities in normal-tension glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Clinical characteristics and prognostic significance of disc hemorrhage in open-angle and angle-closure glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Does the enlargement of retinal nerve fiber layer defects relate to disc hemorrhage or progressive visual field loss in normal-tension glaucoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Risk factors for visual field damage progression in normal-tension glaucoma eyes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

An evidence-based review of prognostic factors for glaucomatous visual field progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Natural history of open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Natural history of normal-tension glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Effect of Ginkgo biloba extract on visual field progression in normal tension glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Optic disc hemorrhages in a population with and without signs of glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Risk factors associated with optic disc haemorrhage in patients with normal tension glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Disc hemorrhages in the glaucomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Factors associated with optic disc hemorrhages in glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Disc hemorrhages and treatment in the early manifest glaucoma trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Optic disc hemorrhages and progression of glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Spatially consistent, localized visual field loss before and after disc hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Optic disk characteristics before the occurrence of disk hemorrhage in glaucoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-014-2767-3

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

21 January 2018

1 reference

12 December 2020

The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group

1 reference

12 December 2020

Risk factors for visual field progression in the low-pressure glaucoma treatment study

1 reference

12 December 2020

Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy

1 reference

12 December 2020

Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study

1 reference

12 December 2020

Visual field progression differences between normal-tension and exfoliative high-tension glaucoma

1 reference

12 December 2020

Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study

1 reference

12 December 2020

Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment

1 reference

12 December 2020

Clinical factors associated with progression of normal-tension glaucoma.

1 reference

12 December 2020

10.1007/S00417-014-2767-3

Identifiers

DOI

1 reference

2 April 2018

PubMed ID

25128961

1 reference

2 April 2018